Nifty

:

25285.35

Sensex

:

82500.82

103.55 (0.41%)
328.72 (0.40%)

Login

Nifty
Sensex

:
:

25285.35
82500.82

103.55 (0.41%)
328.72 (0.40%)

Medicamen Biotech Ltd.

Pharmaceuticals & Drugs - Global

Rating :

34/99

BSE: 531146 | NSE: MEDICAMEQ

Watchlist

NSE BSE

309.95

10-Oct-2025

Open
High
Low
Previous Close

308.2
311.85
300.1
307.35

Volume
Traded Value (lacs)
52 Week High
52 Week Low

13822
4244194.9
630
292.95

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

418.96
44.10
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

448.97
0.32%
1.66

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.45
7.60
4.89

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.95
-6.03
-9.94

PAT CAGR (%)

10 Years
5 Years
3 Years

34.72
-11.57
-23.63

P:E (Median)

8 Years
5 Years
3 Years

59.43
59.56
63.93

P:BV (Average)

8 Years
5 Years
3 Years

4.55
4.55
3.69

EV:EBITDA (Average)

8 Years
5 Years
3 Years

32.48
32.57
30.65

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 38.45 41.48 -7.30% 25.99 45.01 -42.26% 41.14 44.20 -6.92% 42.84 42.67 0.40%
Expenses 34.41 36.62 -6.03% 27.09 38.19 -29.07% 34.90 38.62 -9.63% 36.30 36.52 -0.60%
EBITDA 4.03 4.86 -17.08% -1.09 6.82 - 6.24 5.58 11.83% 6.55 6.15 6.50%
EBIDTM 10.49% 11.72% -4.21% 15.16% 15.17% 12.63% 15.29% 14.42%
Other Income 0.47 0.57 -17.54% 5.22 0.54 866.67% 0.14 0.83 -83.13% 0.29 0.55 -47.27%
Interest 0.56 0.68 -17.65% 0.62 1.87 -66.84% 0.73 0.65 12.31% 1.01 0.91 10.99%
Depreciation 1.77 1.74 1.72% 0.47 1.77 -73.45% 2.17 1.76 23.30% 2.57 1.80 42.78%
PBT 2.17 3.01 -27.91% 3.04 3.73 -18.50% 3.48 4.01 -13.22% 3.25 4.00 -18.75%
Tax 0.53 0.76 -30.26% 0.63 0.62 1.61% 0.96 1.24 -22.58% 0.99 0.99 0.00%
PAT 1.64 2.26 -27.43% 2.41 3.10 -22.26% 2.52 2.77 -9.03% 2.27 3.01 -24.58%
PATM 4.25% 5.44% 9.27% 6.89% 6.13% 6.26% 5.30% 7.06%
EPS 1.20 1.66 -27.71% 1.77 2.28 -22.37% 1.86 2.03 -8.37% 1.67 2.21 -24.43%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 43.05 43.05 0.00% 29.61 47.32 -37.43% 45.14 46.50 -2.92% 44.74 43.54 2.76%
Expenses 38.43 39.60 -2.95% 31.22 41.57 -24.90% 38.44 41.61 -7.62% 39.43 38.90 1.36%
EBITDA 4.62 3.45 33.91% -1.61 5.75 - 6.71 4.89 37.22% 5.32 4.65 14.41%
EBIDTM 10.72% 8.00% -5.43% 12.16% 14.86% 10.52% 11.88% 10.67%
Other Income 0.47 0.59 -20.34% 5.23 0.57 817.54% 0.14 0.83 -83.13% 0.29 0.55 -47.27%
Interest 1.15 0.71 61.97% 0.65 1.89 -65.61% 0.76 0.65 16.92% 1.04 0.91 14.29%
Depreciation 1.80 1.77 1.69% 0.48 1.77 -72.88% 2.21 1.81 22.10% 2.61 1.82 43.41%
PBT 2.13 1.56 36.54% 2.49 2.66 -6.39% 3.88 3.27 18.65% 1.96 2.46 -20.33%
Tax 0.53 0.76 -30.26% 0.63 0.62 1.61% 0.96 1.24 -22.58% 1.05 0.99 6.06%
PAT 1.60 0.80 100.00% 1.86 2.04 -8.82% 2.92 2.03 43.84% 0.91 1.48 -38.51%
PATM 3.72% 1.85% 6.29% 4.32% 6.47% 4.37% 2.02% 3.39%
EPS 1.59 1.06 50.00% 1.90 1.67 13.77% 2.73 1.60 70.62% 1.15 1.17 -1.71%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 148.42 151.46 172.39 137.88 115.45 110.15 117.34 122.60 111.51 82.46 67.28 Net Sales Growth -14.39% -12.14% 25.03% 19.43% 4.81% -6.13% -4.29% 9.95% 35.23% 22.56% Cost Of Goods Sold 80.93 64.01 71.96 52.66 43.51 47.48 59.66 69.26 49.05 37.50 29.05 Gross Profit 67.49 87.46 100.43 85.22 71.93 62.67 57.69 53.34 62.46 44.96 38.23 GP Margin 45.47% 57.74% 58.26% 61.81% 62.30% 56.90% 49.16% 43.51% 56.01% 54.52% 56.82% Total Expenditure 132.70 134.36 145.15 113.27 91.35 90.12 99.22 105.14 94.73 70.87 61.75 Power & Fuel Cost - 6.94 7.12 5.67 5.86 2.68 2.90 2.11 2.78 2.35 2.76 % Of Sales - 4.58% 4.13% 4.11% 5.08% 2.43% 2.47% 1.72% 2.49% 2.85% 4.10% Employee Cost - 21.57 22.12 18.57 14.50 8.79 9.29 8.09 9.05 6.65 4.86 % Of Sales - 14.24% 12.83% 13.47% 12.56% 7.98% 7.92% 6.60% 8.12% 8.06% 7.22% Manufacturing Exp. - 29.25 29.32 27.11 18.12 26.48 21.99 19.85 26.99 16.76 17.05 % Of Sales - 19.31% 17.01% 19.66% 15.70% 24.04% 18.74% 16.19% 24.20% 20.33% 25.34% General & Admin Exp. - 7.07 6.90 5.19 4.92 2.63 3.61 3.29 3.74 4.77 3.56 % Of Sales - 4.67% 4.00% 3.76% 4.26% 2.39% 3.08% 2.68% 3.35% 5.78% 5.29% Selling & Distn. Exp. - 5.22 6.48 2.92 3.36 1.71 1.45 2.33 3.11 2.84 3.92 % Of Sales - 3.45% 3.76% 2.12% 2.91% 1.55% 1.24% 1.90% 2.79% 3.44% 5.83% Miscellaneous Exp. - 0.30 1.25 1.16 1.07 0.34 0.32 0.22 0.01 0.01 3.92 % Of Sales - 0.20% 0.73% 0.84% 0.93% 0.31% 0.27% 0.18% 0.01% 0.01% 0.82% EBITDA 15.73 17.10 27.24 24.61 24.10 20.03 18.12 17.46 16.78 11.59 5.53 EBITDA Margin 10.60% 11.29% 15.80% 17.85% 20.87% 18.18% 15.44% 14.24% 15.05% 14.06% 8.22% Other Income 6.12 6.23 2.31 2.46 1.72 0.75 1.91 3.66 1.89 0.31 0.70 Interest 2.92 3.60 5.65 3.39 1.94 1.51 0.93 1.38 2.71 3.61 3.62 Depreciation 6.98 6.96 7.01 6.35 5.77 2.52 2.50 2.21 2.06 1.92 1.90 PBT 11.94 12.77 16.89 17.33 18.10 16.75 16.60 17.52 13.90 6.36 0.71 Tax 3.11 3.33 3.59 2.33 3.20 4.26 4.34 5.50 3.79 1.20 0.23 Tax Rate 26.05% 26.08% 21.26% 13.44% 17.68% 25.43% 26.14% 31.39% 27.27% 18.87% 32.39% PAT 8.84 9.45 13.30 15.00 14.91 12.49 12.26 12.03 10.11 5.16 0.48 PAT before Minority Interest 8.84 9.45 13.30 15.00 14.91 12.49 12.26 12.03 10.11 5.16 0.48 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.96% 6.24% 7.72% 10.88% 12.91% 11.34% 10.45% 9.81% 9.07% 6.26% 0.71% PAT Growth -20.65% -28.95% -11.33% 0.60% 19.38% 1.88% 1.91% 18.99% 95.93% 975.00% EPS 6.50 6.95 9.78 11.03 10.96 9.18 9.01 8.85 7.43 3.79 0.35

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 162.54 162.55 179.31 140.87 115.45 112.72 125.50 122.60 Net Sales Growth -9.91% -9.35% 27.29% 22.02% 2.42% -10.18% 2.37% Cost Of Goods Sold 83.23 65.87 73.18 53.25 43.51 50.06 65.62 69.26 Gross Profit 79.31 96.68 106.13 87.62 71.93 62.65 59.89 53.34 GP Margin 48.79% 59.48% 59.19% 62.20% 62.30% 55.58% 47.72% 43.51% Total Expenditure 147.52 148.13 155.79 116.53 91.36 93.04 106.03 105.14 Power & Fuel Cost - 6.96 7.14 5.67 5.86 2.68 2.90 2.11 % Of Sales - 4.28% 3.98% 4.02% 5.08% 2.38% 2.31% 1.72% Employee Cost - 30.87 29.07 20.15 14.50 9.00 9.52 8.09 % Of Sales - 18.99% 16.21% 14.30% 12.56% 7.98% 7.59% 6.60% Manufacturing Exp. - 29.26 29.33 27.14 18.12 26.48 21.99 19.85 % Of Sales - 18.00% 16.36% 19.27% 15.70% 23.49% 17.52% 16.19% General & Admin Exp. - 8.72 8.54 5.67 4.93 2.76 3.92 3.29 % Of Sales - 5.36% 4.76% 4.02% 4.27% 2.45% 3.12% 2.68% Selling & Distn. Exp. - 6.13 7.27 3.48 3.36 1.71 1.77 2.33 % Of Sales - 3.77% 4.05% 2.47% 2.91% 1.52% 1.41% 1.90% Miscellaneous Exp. - 0.32 1.27 1.18 1.07 0.34 0.32 0.22 % Of Sales - 0.20% 0.71% 0.84% 0.93% 0.30% 0.25% 0.18% EBITDA 15.04 14.42 23.52 24.34 24.09 19.68 19.47 17.46 EBITDA Margin 9.25% 8.87% 13.12% 17.28% 20.87% 17.46% 15.51% 14.24% Other Income 6.13 6.25 2.33 2.46 1.72 0.75 1.94 3.66 Interest 3.60 3.72 5.67 3.39 1.94 1.51 0.93 1.38 Depreciation 7.10 7.07 7.09 6.37 5.77 2.52 2.50 2.21 PBT 10.46 9.88 13.08 17.05 18.09 16.39 17.98 17.52 Tax 3.17 3.32 3.58 2.32 3.20 4.26 4.69 5.50 Tax Rate 30.31% 33.60% 27.37% 13.61% 17.69% 25.99% 26.08% 31.39% PAT 7.29 6.56 9.49 14.73 14.90 12.13 13.29 12.03 PAT before Minority Interest 9.49 6.56 9.49 14.73 14.90 12.13 13.29 12.03 Minority Interest 2.20 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.49% 4.04% 5.29% 10.46% 12.91% 10.76% 10.59% 9.81% PAT Growth 14.80% -30.87% -35.57% -1.14% 22.84% -8.73% 10.47% EPS 5.36 4.82 6.98 10.83 10.96 8.92 9.77 8.85

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 217.64 209.21 193.80 148.04 134.35 122.48 86.63 74.61 26.78 17.91 Share Capital 12.71 12.71 12.65 12.22 12.22 12.22 11.70 11.70 10.52 9.99 Total Reserves 204.92 196.49 180.02 135.82 122.14 110.26 74.93 62.91 15.49 7.92 Non-Current Liabilities 0.16 0.21 0.66 6.04 7.84 3.58 1.42 1.73 3.95 4.87 Secured Loans 0.76 0.95 0.87 5.07 6.40 2.36 0.02 0.14 2.46 3.52 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 2.20 1.76 1.66 1.46 1.16 1.06 0.98 1.18 0.85 0.61 Current Liabilities 72.58 82.30 80.46 71.13 50.27 50.40 48.54 41.21 42.67 37.24 Trade Payables 41.16 37.97 45.51 41.74 29.58 31.96 30.57 21.80 22.31 18.76 Other Current Liabilities 0.85 10.70 7.21 5.03 4.99 5.59 0.78 0.87 4.81 3.20 Short Term Borrowings 26.45 28.64 23.31 19.27 10.93 7.62 11.61 14.24 14.09 14.76 Short Term Provisions 4.12 4.99 4.43 5.09 4.78 5.23 5.58 4.30 1.46 0.53 Total Liabilities 290.38 291.72 274.92 225.21 192.46 176.46 136.59 117.55 73.40 60.02 Net Block 86.31 91.10 92.36 92.48 89.64 33.69 24.38 25.34 19.05 19.10 Gross Block 137.77 135.86 130.12 124.26 115.66 57.74 46.58 45.78 37.66 35.79 Accumulated Depreciation 51.46 44.75 37.76 31.78 26.02 24.05 22.20 20.45 18.61 16.69 Non Current Assets 130.26 132.73 109.98 96.48 93.37 77.17 40.01 26.46 20.02 19.42 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 40.50 14.76 0.28 0.45 0.00 Non Current Investment 8.06 7.76 4.08 2.06 2.06 2.06 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 1.24 1.20 1.09 0.87 0.78 0.63 0.58 0.57 0.52 0.32 Other Non Current Assets 34.64 32.67 12.46 1.08 0.90 0.29 0.29 0.28 0.00 0.00 Current Assets 153.51 152.37 157.97 120.98 92.43 97.24 96.17 90.99 53.38 40.60 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.07 0.02 Inventories 62.14 59.33 45.06 27.01 5.20 16.96 15.26 14.23 13.79 11.14 Sundry Debtors 58.62 48.29 60.23 61.18 49.75 43.93 43.37 38.42 25.69 16.09 Cash & Bank 3.58 14.62 20.44 3.81 3.08 2.23 8.52 22.66 2.97 2.72 Other Current Assets 29.17 2.34 2.58 20.28 34.39 34.12 29.01 15.60 10.87 10.63 Short Term Loans & Adv. 26.49 27.80 29.66 8.69 11.44 12.60 14.41 1.50 9.01 8.45 Net Current Assets 80.93 70.07 77.51 49.85 42.16 46.85 47.62 49.78 10.71 3.35 Total Assets 290.39 291.72 274.91 225.20 192.46 176.45 136.60 117.55 73.40 60.02

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 213.05 206.98 193.41 146.47 132.89 121.22 86.63 Share Capital 12.71 12.71 12.65 12.22 12.22 12.22 11.70 Total Reserves 200.34 194.27 178.16 134.25 120.67 109.00 74.93 Non-Current Liabilities 3.11 0.50 0.65 6.04 7.84 3.58 1.42 Secured Loans 3.73 1.26 0.87 5.07 6.40 2.36 0.02 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 2.20 1.76 1.66 1.46 1.16 1.06 0.98 Current Liabilities 78.16 84.56 82.57 72.69 53.27 56.48 48.54 Trade Payables 42.65 38.95 47.59 43.30 32.21 37.38 30.57 Other Current Liabilities 1.47 11.06 7.28 5.03 4.90 5.91 0.78 Short Term Borrowings 29.52 29.56 23.31 19.27 10.93 7.62 11.61 Short Term Provisions 4.52 4.99 4.39 5.09 5.23 5.57 5.58 Total Liabilities 294.32 292.04 276.63 225.20 194.00 181.28 136.59 Net Block 87.10 91.85 92.66 92.48 89.64 33.69 24.38 Gross Block 138.78 136.70 130.43 124.26 115.66 57.74 46.58 Accumulated Depreciation 51.67 44.85 37.77 31.78 26.02 24.05 22.20 Non Current Assets 122.99 125.74 106.22 94.42 91.31 75.11 40.01 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 40.50 14.76 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 1.24 1.22 1.11 0.87 0.78 0.63 0.58 Other Non Current Assets 34.64 32.67 12.46 1.08 0.90 0.29 0.29 Current Assets 164.55 159.59 163.36 123.04 96.03 104.13 96.17 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 62.14 59.38 45.06 27.01 5.20 16.96 15.26 Sundry Debtors 68.90 55.26 65.26 63.22 52.55 49.96 43.37 Cash & Bank 3.76 14.79 20.78 3.82 3.89 3.09 8.52 Other Current Assets 29.76 2.34 2.58 20.28 34.39 34.12 29.01 Short Term Loans & Adv. 27.07 27.84 29.69 8.69 11.44 12.60 14.41 Net Current Assets 86.39 75.04 80.79 50.35 42.76 47.65 47.62 Total Assets 294.32 292.03 276.64 225.20 194.00 181.28 136.60

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -2.63 -0.25 -3.50 4.81 12.98 11.71 4.30 -5.45 3.59 6.21 PBT 12.77 16.89 17.33 18.10 16.75 16.60 17.35 13.90 6.36 0.48 Adjustment 9.51 10.67 8.56 7.04 3.43 2.81 2.24 4.28 4.88 5.12 Changes in Working Capital -23.57 -24.74 -32.52 -17.13 -2.74 -3.35 -11.29 -23.14 -7.65 0.61 Cash after chg. in Working capital -1.29 2.82 -6.62 8.01 17.44 16.06 8.30 -4.95 3.59 6.21 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.35 -3.06 3.12 -3.20 -4.46 -4.35 -4.00 -0.50 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1.72 -8.71 -7.54 -8.47 -17.81 -39.35 -14.76 -7.99 -2.30 -1.05 Net Fixed Assets -1.91 -5.74 -5.86 -8.60 -17.42 -36.90 -15.28 -7.95 -2.32 -0.85 Net Investments -0.30 -3.68 -2.02 0.00 0.00 -2.06 0.07 0.00 -0.05 0.00 Others 0.49 0.71 0.34 0.13 -0.39 -0.39 0.45 -0.04 0.07 -0.20 Cash from Financing Activity -6.68 3.14 27.67 4.39 5.68 21.36 -3.69 33.14 -1.04 -4.73 Net Cash Inflow / Outflow -11.04 -5.82 16.63 0.73 0.85 -6.29 -14.15 19.70 0.25 0.42 Opening Cash & Equivalents 14.62 20.44 3.81 3.08 2.23 8.52 22.66 2.97 2.72 2.29 Closing Cash & Equivalent 3.58 14.62 20.44 3.81 3.08 2.23 8.52 22.66 2.97 2.72

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity -8.16 -6.74 -6.29 4.11 12.77 12.80 4.30 PBT 9.88 13.08 17.05 18.09 16.39 17.98 17.35 Adjustment 9.56 10.77 8.56 7.04 3.43 2.81 2.24 Changes in Working Capital -26.25 -27.52 -28.78 -17.82 -2.59 -3.64 -11.29 Cash after chg. in Working capital -6.81 -3.68 -3.17 7.31 17.23 17.15 8.30 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.35 -3.06 -3.12 -3.20 -4.46 -4.35 -4.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1.40 -5.56 -5.88 -8.47 -17.81 -37.29 -14.76 Net Fixed Assets -1.91 -5.74 -5.86 -8.60 -17.42 -36.90 Net Investments -0.30 -3.68 -2.02 0.00 0.00 -2.06 Others 0.81 3.86 2.00 0.13 -0.39 1.67 Cash from Financing Activity -1.47 6.31 29.13 4.30 5.84 19.06 -3.69 Net Cash Inflow / Outflow -11.03 -5.99 16.95 -0.07 0.80 -5.43 -14.15 Opening Cash & Equivalents 14.79 20.78 3.82 3.89 3.09 8.52 22.66 Closing Cash & Equivalent 3.76 14.79 20.78 3.82 3.89 3.09 8.52

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 165.97 159.34 146.79 114.84 104.52 98.58 73.69 63.68 24.73 17.92 ROA 3.25% 4.69% 6.00% 7.14% 6.77% 7.83% 9.46% 10.59% 7.74% 0.75% ROE 4.57% 6.85% 9.20% 11.12% 10.06% 11.86% 14.96% 20.12% 23.50% 2.76% ROCE 6.96% 10.13% 10.95% 12.82% 13.12% 15.26% 20.22% 24.91% 24.10% 11.36% Fixed Asset Turnover 1.11 1.30 1.08 0.96 1.27 2.25 2.65 2.68 2.25 1.90 Receivable days 128.81 114.88 160.69 175.37 155.22 135.78 121.75 104.83 92.47 115.48 Inventory Days 146.35 110.51 95.39 50.92 36.72 50.11 43.90 45.82 55.17 66.68 Payable days 225.62 211.72 302.36 299.07 236.52 114.92 91.29 86.27 110.47 140.55 Cash Conversion Cycle 49.54 13.66 -46.28 -72.78 -44.58 70.96 74.36 64.38 37.17 41.61 Total Debt/Equity 0.13 0.15 0.14 0.18 0.15 0.10 0.14 0.19 0.68 1.14 Interest Cover 4.55 3.99 6.11 10.33 12.08 18.83 13.68 6.13 2.76 1.20

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 162.23 157.52 145.25 113.56 103.33 97.55 73.69 ROA 2.24% 3.34% 5.87% 7.11% 6.46% 8.36% 8.80% ROE 3.23% 4.94% 9.13% 11.25% 9.89% 12.94% 13.95% ROCE 5.77% 8.46% 10.85% 12.94% 12.99% 16.54% 19.30% Fixed Asset Turnover 1.18 1.34 1.11 0.96 1.30 2.41 2.63 Receivable days 139.40 122.66 166.45 183.01 165.97 135.71 129.12 Inventory Days 136.43 106.29 93.37 50.92 35.88 46.85 45.43 Payable days 226.08 215.82 311.49 316.67 253.69 117.21 106.58 Cash Conversion Cycle 49.75 13.14 -51.67 -82.73 -51.84 65.35 67.97 Total Debt/Equity 0.16 0.16 0.14 0.19 0.15 0.10 0.14 Interest Cover 3.66 3.31 6.03 10.32 11.85 20.30 13.68

Top Investors:

pharmadanica a/s

veralogix holdings(pty) ltd

ginnerup capital aps

investor education and protection fund (iepf)

ritesh kantilal oswal

Annual Reports:

News Update:

Medicamen Biotech - Quarterly Results
12th Aug 2025, 16:35 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback